Vanguard Group’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $97.1K | Buy |
30,061
+9,089
| +43% | +$29.4K | ﹤0.01% | 4181 |
|
|
2025
Q3 | $51.2K | Hold |
20,972
| – | – | ﹤0.01% | 4297 |
|
|
2025
Q2 | $102K | Hold |
20,972
| – | – | ﹤0.01% | 4148 |
|
|
2025
Q1 | $30.4K | Hold |
20,972
| – | – | ﹤0.01% | 4225 |
|
|
2024
Q4 | $39.8K | Sell |
20,972
-24,376
| -54% | -$54.2K | ﹤0.01% | 4225 |
|
|
2024
Q3 | $149K | Sell |
45,348
-17,567
| -28% | -$63.1K | ﹤0.01% | 4165 |
|
|
2024
Q2 | $440K | Hold |
62,915
| – | – | ﹤0.01% | 4043 |
|
|
2024
Q1 | $1.14M | Sell |
62,915
-10
| -0% | -$200 | ﹤0.01% | 3767 |
|
|
2023
Q4 | $667K | Hold |
62,925
| – | – | ﹤0.01% | 3950 |
|
|
2023
Q3 | $1.24M | Buy |
62,925
+2,180
| +4% | +$93.9K | ﹤0.01% | 3755 |
|
|
2023
Q2 | $4.65M | Sell |
60,745
-293
| -0.5% | -$23.7K | ﹤0.01% | 3343 |
|
|
2023
Q1 | $5.77M | Buy |
61,038
+53
| +0.1% | +$5.05K | ﹤0.01% | 3232 |
|
|
2022
Q4 | $5.94M | Sell |
60,985
-98
| -0.2% | -$14.2K | ﹤0.01% | 3221 |
|
|
2022
Q3 | $15.8M | Sell |
61,083
-889
| -1% | -$258K | ﹤0.01% | 2739 |
|
|
2022
Q2 | $11.5M | Sell |
61,972
-9,886
| -14% | -$945K | ﹤0.01% | 2917 |
|
|
2022
Q1 | $7.03M | Sell |
71,858
-5,700
| -7% | -$732K | ﹤0.01% | 3339 |
|
|
2021
Q4 | $12.7M | Sell |
77,558
-5,014
| -6% | -$1.1M | ﹤0.01% | 3094 |
|
|
2021
Q3 | $22.5M | Sell |
82,572
-22,611
| -21% | -$6.91M | ﹤0.01% | 2803 |
|
|
2021
Q2 | $41.7M | Sell |
105,183
-1,800
| -2% | -$840K | ﹤0.01% | 2468 |
|
|
2021
Q1 | $57.8M | Buy |
106,983
+520
| +0.5% | +$324K | ﹤0.01% | 2236 |
|
|
2020
Q4 | $40.2M | Buy |
106,463
+4,573
| +4% | +$1.82M | ﹤0.01% | 2317 |
|
|
2020
Q3 | $38.5M | Sell |
101,890
-1,341
| -1% | -$592K | ﹤0.01% | 2140 |
|
|
2020
Q2 | $50.8M | Buy |
103,231
+2,189
| +2% | +$976K | ﹤0.01% | 2004 |
|
|
2020
Q1 | $37.1M | Buy |
101,042
+17,075
| +20% | +$8.84M | ﹤0.01% | 2000 |
|
|
2019
Q4 | $59.4M | Buy |
83,967
+9,485
| +13% | +$6.53M | ﹤0.01% | 2019 |
|
|
2019
Q3 | $47.8M | Sell |
74,482
-550
| -0.7% | -$436K | ﹤0.01% | 2094 |
|
|
2019
Q2 | $65.6M | Buy |
75,032
+7,787
| +12% | +$5.35M | ﹤0.01% | 1962 |
|
|
2019
Q1 | $38.8M | Buy |
67,245
+30,025
| +81% | +$12.6M | ﹤0.01% | 2217 |
|
|
2018
Q4 | $10.4M | Sell |
37,220
-21,338
| -36% | -$8.44M | ﹤0.01% | 2758 |
|
|
2018
Q3 | $28.1M | Buy |
58,558
+1,296
| +2% | +$556K | ﹤0.01% | 2420 |
|
|
2018
Q2 | $25.9M | Buy |
57,262
+1,061
| +2% | +$673K | ﹤0.01% | 2451 |
|
|
2018
Q1 | $33M | Sell |
56,201
-415
| -0.7% | -$259K | ﹤0.01% | 2285 |
|
|
2017
Q4 | $35.2M | Buy |
56,616
+2,035
| +4% | +$1.46M | ﹤0.01% | 2244 |
|
|
2017
Q3 | $50.3M | Buy |
54,581
+2,151
| +4% | +$1.91M | ﹤0.01% | 2040 |
|
|
2017
Q2 | $48.9M | Buy |
52,430
+3,693
| +8% | +$3.62M | ﹤0.01% | 2028 |
|
|
2017
Q1 | $46.3M | Buy |
48,737
+2,645
| +6% | +$2.46M | ﹤0.01% | 2046 |
|
|
2016
Q4 | $37M | Buy |
46,092
+1,298
| +3% | +$1.17M | ﹤0.01% | 2122 |
|
|
2016
Q3 | $37.8M | Sell |
44,794
-48
| -0.1% | -$38.6K | ﹤0.01% | 2062 |
|
|
2016
Q2 | $36.9M | Buy |
44,842
+1,029
| +2% | +$1.12M | ﹤0.01% | 2032 |
|
|
2016
Q1 | $48.8M | Buy |
43,813
+1,210
| +3% | +$1.24M | ﹤0.01% | 1871 |
|
|
2015
Q4 | $53.1M | Buy |
42,603
+13,169
| +45% | +$21.8M | ﹤0.01% | 1856 |
|
|
2015
Q3 | $39.8M | Buy |
29,434
+1,364
| +5% | +$2.25M | ﹤0.01% | 1979 |
|
|
2015
Q2 | $50.5M | Buy |
28,070
+7,133
| +34% | +$11.1M | ﹤0.01% | 1943 |
|
|
2015
Q1 | $33.8M | Buy |
20,937
+2,790
| +15% | +$4.14M | ﹤0.01% | 2106 |
|
|
2014
Q4 | $13.8M | Buy |
18,147
+224
| +1% | +$119K | ﹤0.01% | 2406 |
|
|
2014
Q3 | $7.1M | Sell |
17,923
-1,117
| -6% | -$538K | ﹤0.01% | 2657 |
|
|
2014
Q2 | $11.5M | Buy |
19,040
+2,114
| +12% | +$1.18M | ﹤0.01% | 2443 |
|
|
2014
Q1 | $11.6M | Buy |
16,926
+726
| +4% | +$486K | ﹤0.01% | 2411 |
|
|
2013
Q4 | $10.5M | Buy |
16,200
+2,415
| +18% | +$1.44M | ﹤0.01% | 2435 |
|
|
2013
Q3 | $8.17M | Buy |
13,785
+1,576
| +13% | +$710K | ﹤0.01% | 2491 |
|
|
2013
Q2 | $3.85M | Buy |
+12,209
| New | +$3.39M | ﹤0.01% | 2801 |
|
Other funds holding TCRT
HF
TRCT
Vanguard Group's TCRT Position: Q4 2025 in Review
Vanguard Group increased its Alaunos Therapeutics (TCRT) stake by 43% in Q4 2025, buying an estimated $29.4K and bringing the position to 30,061 shares worth $97.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4181.
Vanguard Group first reported a position in TCRT in Q2 2013 and has held it in 51 quarters since. The position peaked at $65.6M in Q2 2019. 27 funds tracked by Wall St. Rank hold TCRT as of Q4 2025.
- Vanguard Group held 30,061 shares of Alaunos Therapeutics worth $97.1K as of Q4 2025.
- Vanguard Group bought 9,089 Alaunos Therapeutics shares in Q4 2025, an estimated $29.4K.
- Alaunos Therapeutics made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4181 holding.
- Vanguard Group first reported a position in Alaunos Therapeutics in Q2 2013 and has held it in 51 quarters since.
- Vanguard Group's Alaunos Therapeutics position peaked at $65.6M in Q2 2019.
- 27 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.